secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001558370-25-009163
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure approves 1-for-12 reverse stock split effective July 14, 2025
----------------------------------------------------------------------

- Board approved 1:12 reverse stock split; effective July 14, 2025 with split-adjusted trading at market open.
- Every 12 shares convert into 1 share; fractional shares paid in cash based on prior day's closing price.
- Outstanding equity awards, incentive plans, and exercise prices adjusted proportionally to the split.
- No change to common stock par value; trading symbol remains NXTC on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025009163/0001558370-25-009163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025009163/nxtc-20250710x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer